Genomic screening for rare diseases in newborns
Official title: Genomic Uniformed-Screening Against Rare Disease In All Newborns
Run by Columbia University · NCT05990179 · Data updated 2026-11-12
This study is testing if using advanced genetic testing for newborns can help find rare diseases earlier so that families can get support and treatment options sooner.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Day to 1 Month |
| Sex | All |
| Enrollment | 100000 (estimated) |
| Sponsor | Columbia University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | September 6, 2022 |
| Main results expected | September 2029 |
| Study ends | September 2029 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT05990179 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are newborns admitted to well-baby nurseries who are born after 33 weeks of gestation and whose parents speak English, Mandarin, or Spanish.
✕Probably not a fit
Patients who may not benefit from this study include those born before 33 weeks of gestation or whose parents do not speak the eligible languages.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to explore the use of genomic sequencing technology to expand the range of conditions screened in newborns beyond the standard newborn screening panel. Families will have the option to participate in additional screenings for conditions that may have effective treatments available or for which early intervention could improve outcomes. The study emphasizes equity in healthcare by ensuring all newborns have access to potentially life-saving information. Collaboration among parents, hospitals, and health departments is essential for the successful implementation of this expanded screening approach.
Why it matters
Potential benefit: If successful, this could lead to earlier detection and treatment of rare genetic conditions in newborns, improving health outcomes.
How similar studies have gone: Other studies have shown promise in using genomic sequencing for newborn screening, indicating a growing interest and potential in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Newborns admitted to the well-baby nurseries from the recruiting hospitals * Newborns born after 33 weeks of gestation * Newborns whose parents are English, Mandarin, or Spanish speaking
Where it's running
-
Columbia University Irving Medical Center/NYP
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Wendy K. Chung, MD, PhD — Boston Children's Hospital
- Study coordinator: Anah Hetzler
- Email: ak3578@cumc.columbia.edu
- Phone: 212-305-5508
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone-based EEG to detect hidden awareness in ICU patients with brain injuries
Researchers will test a smartphone-enabled EEG to see if it can reveal Cognitive Motor Dissociation in ICU patients who can’t show commands at bedside.
-
Decision support tools to help high-risk women consider breast cancer chemoprevention
A web-based decision aid plus standard materials will see if reminders and information help high-risk women start medications like tamoxifen more often.
-
EHR-based approach to boost HBOC genetic testing in at-risk women
A new EHR tool-based program tests whether computer prompts and real patient resources can help more women with family histories of breast or ovarian cancer get HBOC genetic testing.
-
Preoperative Music to Ease Anxiety Before Hip or Knee Replacement
Patients awaiting hip or knee replacement listen to their own music through noise‑canceling headphones to see if it lowers preoperative anxiety.
-
Post-Vasectomy Pain Management Aftercare
This study tests four pain-control regimens after vasectomy to see which helps men feel better and how much pain relief they get.
-
Sleep patterns to help predict waking from brain injury
Doctors are testing whether brain activity during sleep can help predict when a person with a serious brain injury will regain awareness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.